Transcriptional repression of type I IFN genes

Biochimie

Volumn 80, Issue 8-9, 1998, Pages 689-701

  Lopez, Sébastien ^a   Navarro, Sébastien ^a  

^a CNRS   (France)

Author keywords

IFN A; IFN B; Transcriptional repression

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; INTERFERON; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0032131234     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80022-4     Document Type: Article

References (139)

1. [1] Tjian R., Maniatis T., Transcriptional activation: a complex puzzle with few easy pieces, Cell 77 (1994) 5-8.
2. [2] Levine M., Manley J.L., Transcriptional repression of eucaryotic promoters, Cell 59 (1989) 405-408.
3. [3] Renkawitz R., Transcriptional repression in eukaryotes, Trends Genet. Sci. 6 (1990) 192-196.
4. [4] Goodbourn S., Negative regulation of transcriptional initiation in eukaryotes, Biochim. Biophys. Acta 1032 (1990) 53-77.
5. [5] Clark A.R., Docherty K., Negative regulation of transcription in eukaryotes, Biochem. J. 296 (1993) 521-541.
6. [6] Johnson A.D., The price of repression, Cell 81 (1995) 655-658.
7. [7] Hanna-Rose W., Hansen U., Active repression mechanisms of eukaryotic transcription repressors, Trends Genet. Sci. 12 (1996) 229-234.
8. [8] Gray S., Levine M., Transcriptional repression in development, Curr. Opin. Cell Biol. 8 (1996) 358-364.
9. [9] Croston G.E., Kerrigan L.A., Lira L.M., Marshak D.R., Kadonaga J.T., Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription, Science 251 (1991) 643-649.
10. [10] Stover D.M., Zehner Z.E., Identification of a cis-acting DNA antisilencer element which modulates vimentin gene expression, Mol. Cell. Biol. 12 (1992) 2230-2240.
11. [11] Frenkel B., Montecino M., Stein J.L., Lian J.B., Stein G.S., A composite intragenic silencer domain exhibits negative and positive transcriptinal control of the bone-specific osteocalcin gene: promoter and cell type requirements, Proc. Natl. Acad. Sci. USA 91 (1994) 10923-10927.
12. [12] Goping I.S., Shore G.C., Interactions between repressor and anti-repressor elements in the carbamyl phosphate synthethase I promoter, J. Biol. Chem. 269 (1994) 3891-3896.
13. [13] Sledjeski D., Gottesman S., A small RNA acts as an antisilencer of the H-NS-silenced rcsA gene of Eschericha coli, Proc. Natl. Acad. Sci. USA 92 (1995) 2003-2007.
14. [14] Ye J., Young H.A., Negative regulation of cytokine gene transcription, FASEB J. 11 (1997) 825-833.
15. [15] Dandoy F., Kelley K.A., De Maeyer-Guignard J., DeMaeyer E., Pitha P.M., Linkage analysis of the murine interferon alpha locus on chromosome 4, J. Exp. Med. 160 (1984) 294-302.
16. [16] Henco K., Brosius J., Fujisawa A., Fujisawa J.I., Haynes J.R., Hochstadt J., Kovacic T., Pasek M., Schambock A., Schmid J., Todokora K., Walchli M., Nagata S., Weissmann C., Structural relationship of human interferon alpha genes and pseudogenes, J. Mol. Biol. 185 (1985) 227-260.
17. [17] DeMaeyer E., Dandoy F., Linkage analysis of the murine interferon alpha locus (Ifa) on chromosome 4, J. Hered. 78 (1987) 143-146.
18. [18] De Maeyer E., De Maeyer-Guignard J., Interferons and other regulatory cytokines, John Wiley and Sons, New York, 1988.
19. [19] Diaz M.O., Pomykala H.M., Bohlander S.K., Maltepe E., Malik K., Brownstein B., Olopade O.I., Structure of the human type-I interferon gene cluster determined from a YAC clone contig, Genomics 2 (1994) 540-552.
20. [20] Diaz M.O., The human type I interferon gene cluster, Semin. Virol. 6 (1995) 143-149.
21. [21] Shuttleworth J., Morser J., Burke D.C., Expression of interferon-α and interferon-β genes in human lymphoblastoid (Namalwa) cells, Eur. J. Biochem 13 (1983) 399-404.
22. [22] Kelley K.A., Pitha P.M., Differential effect of poly rI-rC and Newcastle Disease Virus on the expression of interferon and cellular genes in mouse cells, Virology 147 (1985) 382-393.
23. [23] Kelley K.A., Pitha P.M., Characterization of a mouse interferon gene locus II. Differential expression of alpha interferon genes, Nucleic Acids Res. 13 (1985) 825-839.
24. [24] Weissmann C., Weber H., The interferon genes, Prog. Nucleic Acids Res. Mol. Biol. 12 (1986) 251-300.
25. [25] Maniatis T., Whittemore L.A., Du W., Fan C.M., Keller A.D., Palombella V.J., Thanos D.N., Positive and negative control of human Interferon-β gene expression, in: in: Mcknight S.L., Yamamoto K.R.Transcriptional Regulation, vol. II, (Eds.), C. Press, New-York, 1992, pp. 1193-1220.
26. [26] Tanaka N., Taniguchi T., Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system, Adv. Immunol. 52 (1992) 263-281.
27. [27] Pitha P.M., Au W.E., Induction of interferon alpha genes expression, Semin. Virol. 6 (1995) 151-159.
28. [28] Hiscott J., Nguyen H., Lin R., Molecular mechanisms of interferon β gene induction, Semin. Virol. 6 (1995) 161-173.
29. [29] Whittemore L.A., Maniatis T., Postinduction turnoff of β-interferon gene expression, Mol. Cell. Biol. 64 (1990) 1329-1337.
30. [30] Raj N.B.K., Pitha P.M., 65-κDa protein binds to destabilizing sequences in the IFN-β mRNA coding and 3'UTR, FASEB J. 7 (1993) 702-710.
31. [31] Ryals J., Dierks P., Ragg H., Weissmann C., A 46-nucleotide promoter segment from an IFN-α gene renders an unrelated promoter inducible by virus, Cell 41 (1985) 497-507.
32. [32] Fujita T., Ohno S., Yasumitsu H., Taniguchi T., Delimitation and properties of DNA sequences required for the regulated expression of human interferon-β gene, Cell 41 (1985) 489-196.
33. [33] Goodbourn S., Zinn K., Maniatis T., Human β-interferon gene expresion is regulated by an inducible enhancer element, Cell 41 (1985) 509-520.
34. [34] Fujita T., Ahibuya H., Hotta H., Yamanishi K., Taniguchi T., Interferon β gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus inducible enhancer, Cell 49 (1987) 357-367.
35. [35] Fan C.M., Maniatis T., Two different virus-inducible elements are required for human β-IFN gene regulation, EMBO J. 8 (1989) 101-110.
36. [36] Goodbourn S., Burstein H., Maniatis T., The human β-interferon gene enhancer is under negative control, Cell 45 (1986) 601-610.
37. [37] Zinn K., Dimaio D., Maniatis T., Identification of two distinct regulatory regions adjacent to the human β-interferon gene, Cell 34 (1983) 865-879.
38. [38] Zinn K., Maniatis T., Detection of factors that interact with the human β-interferon regulatory region in vivo by DNAse I footprinting: dissociation and binding correlate with gene activity, Cell, 45 (1986) 611-618.
39. [39] Whittemore L.A., Maniatis T., Postinduction repression of the β-interferon gene is mediated through two positive regulatory domains, Proc. Natl. Acad. Sci. USA 87 (1990) 7799-7803.
40. [40] Dirks W., Mittnacht S., Rentrop M., Hauser H., Isolation and functional characterization of the murine Interferon β1 promoter, J. Interferon Res. 9 (1989) 125-133.
41. [41] Vodjdani G., Coulombel C., Doly J., Structure and characterization of a murine chromosomal fragment containing the Interferon β gene, J. Mol. Biol. 204 (1988) 221-231.
42. [42] Goodbourn S., Maniatis T., Overlapping positive and negative regulatory domains of the human β-interferon gene, Proc. Natl. Acad. Sci. USA 85 (1988) 1447-1451.
43. [43] Nourbakhsh M., Hoffman K., Hauser H., Interferon-β promoters contain a DNA element that acts as a position-independent silencer on the NF-κB site, EMBO J. 12 (1993) 451-459.
44. [44] Kuhl D., De LaFuente J., Chaturvedi M., Parimoo S., Ryals J., Meyer F., Weissmann C., Reversible silencing of enhancers by sequences derived from the human IFN-α promoter, Cell 50 (1987) 1057-1069.
45. [45] Haggarty A., Ponton A., Paterno G., Daigneault L.J., Skup D., An embryonic DNA-binding protein specific for a region of the human β-interferon promoter, Nucleic Acids Res. 16 (1988) 10575-10592.
46. [46] Haggarty A., Camato R., Paterno G., Cohen L., Hiscott J., Skup D., A developmentally regulated octamer-binding activity in embryoma carcinoma cells which represses β-interferon expression, Cell Growth Diff. 2 (1991) 503-510.
47. [47] Barlow D.P., Randle J.R., Burke D.C., Interferon synthesis in the early post-implantation mouse embryo, Differentiation 27 (1984) 229-235.
48. [48] Raj N.B.K., Israeli R., Kellum M., Pitha P.M., Upstream regulatory elements of murine α4-interferon gene confer inducibility and cell type-restricted expression, J. Biol. Chem. 264 (1989) 11149-11157.
49. [49] Macdonald N.J., Kuhl D., Maguire D., Naf D., Gallant P., Goswamy A., Hug H., Büeler H., Chaturvedi M., De LaFuente J., Ruffner H., Meyer F., Weissmann C., Different pathways mediate virus inducibility of the human IFN-β genes, Cell 60 (1990) 767-779.
50. [50] Hiscott J., Cantell K., Weissmann C., Differential expression of human Interferon genes, Nucleic Acids Res. 12 (1984) 3727-3746.
51. [51] Asano M., Hayashi M., Yoshida E., Kawade Y., Iwakura Y., Induction of interferon-α by interferon-β, but not of interferon-β by interferon-α, in the mouse, Virology 176 (1990) 30-38.
52. [52] Raj N.B.K., Au W.C., Pitha P.M., Indentification of a novel virus-responsive sequence in the promoter of murine interferon-α genes, J. Biol. Chem. 266 (1991) 11360-11365.
53. [53] Zwarthoff E.C., Moren A.T.A., Trapman J., Organization, structure and expression of murine interferon α genes, Nucleic Acids Res. 13 (1985) 791-804.
54. [54] Dion M., Vodjdani G., Doly J., Sequence and expression of a novel murine interferon a gene: homology with enhancer elements in the regulatory region of the gene, Biochem Biophys. Res. Commun. 138 (1986) 826-834.
55. [55] Bisat F., Raj N.B.K., Pitha P.M., Differential and cell type specific expression of murine α-interferon genes is regulated on the transcriptional level, Nucleic Acids Res. 16 (1988) 6067-6083.
56. [56] Hoss-Homfeld A., Zwarthoff E.C., Zawatzky R., Cell type specific expression and regulation of murine interferon α and β genes, Virology 173 (1989) 539-550.
57. [57] Navarro S., Dion M., Vodjdani G., Berlot-Picard F., Doly J., Isolation and characterization of a functional murine interferon α gene which is not expressed in fibroblasts upon virus induction, J. Gen. Virol. 70 (1989) 1831-1839.
58. [58] Coulombel C., Vodjdani G., Doly J., Isolation and characterization of a novel interferon-α-encoding gene, IFN-α 11, within a murine IFN cluster, Gene 104 (1991) 187-195.
59. [59] Civas A., Dion M., Vodjdanii G., Doly J., Repression of the murine interferon α 11 gene: identification of negatively acting sequences, Nucleic Acids Res. 16 (1991) 4497-4502.
60. [60] Au W.C., Raj N.B.K., Pine R., Pitha P.M., Distinct activation of murine interferon-α promoter region by IRF-1/ISFG-2 and virus infection, Nucleic Acids Res. 20 (1992) 2877-2884.
61. [61] Au W.C., Su Y., Raj N.B.K., Pitha P.M., Virus mediated induction of interferon A gene requiRes. cooperation between multiple binding factors in the interferon α promoter region, J. Biol. Chem. 268 (1993) 24032-24040.
62. [62] Génin P., Bragança J., Darracq N., Doly J., Civas A., A novel PRDI and TG-binding activity involved in the virus-induced transcription of the IFN-A genes, Nucleic Acids Res. 23 (1995) 5055-5063.
63. [63] Dent C.I., Gewert D.R., A regulatory domain within the virus-response element of the interferon α1 gene acts as a transcripα tional repressor sequence and determinant of cell-specific gene expression, Fur. J. Biochem. 236 (1996) 895-903.
64. [64] Dent C.L., Macbride S.J., Sharp N.A., Gewert D.R., Relative transcriptional inducibility of the human interferon-α subtypes conferred by the virus-responsive enhancer sequence, J. Interferon Cytokine Res. 16 (1996) 99-107.
65. [65] Bragança J., Génin P., Bandu M.T., Darracq N., Vignal M., Cassé C., Doly J., Civas A., Synergism between multiple virus-induced-factor-binding elements involved in the differential expression of IFN-A genes, J. Biol. Chem. 272 (1997) 22154-22162.
66. [66] Näf D., Hardin S.E., Weissmann C., Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element, Proc. Natl. Acad. Sci. USA 88 (1991) 1369-1373.
67. [67] Roffet P., Lopez S., Navarro S., Bandu M.T., Coulombel C., Vignal M., Doly J., Vodjdani G., Identification of distal silencing elements in the murine interferon-A 11 gene promoter, Biochem J. 317 (1996) 697-706.
68. [68] Chung K.C., Huang D., Chen Y., Short S., Short M.L., Zhang Z., Jungmann R.A., Identification of a silencer module which selectively represses cyclic AMP-responsive element-dependent gene expression, Mol. Cell. Biol, 15 (1995) 6139-6149.
69. [69] Lopez S., Reeves R., Island M.L., Bandu M.T., Christeff N., Doly J., Navarro S., Silencer activity in the interferon A gene promoters, J. Biol. Chem. 272 (1997) 22788-22800.
70. [70] Harada H., Fujita M., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T., Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes, Cell 58 (1989) 729-739.
71. [71] Tanaka N., Kawakami T., Taniguchi T., Recognition DNA sequences of Interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system, Mol. Cell. Biol. 13 (1993) 4531-4538.
72. [72] Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kündig T., Amakawa R., Kishihara K., Wakeman A., Potter J., Furlonger C.L., Narendran A., Suzuki H., Ohashi P.S., Paige C.J., Taniguchi T., Mak T.W., Targeted disruption of IRF-1 or IRF-2 results in abnormal type 1 IFN gene induction and aberrant lymphocyte development, Cell 75 (1993) 83-97.
73. [73] Vikek J., Interferons, in: Sporn M.A., Roberts B. (Eds.), Peptide growth factors and their receptors, Handbook of experimental pharmacology, Springer-Verlag, Berlin, 1990, pp. 3-38.
74. [74] Ruffner H., Reis L.F.L., Näf D., Weissmann C., Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1, Proc. Natl. Acad. Sci. USA 90 (1993) 11503-11507.
75. [75] Kawakami T., Matsumoto M., Sato M., Harada H., Taniguchi T., Kitagawa M., Possible involvement of the transcription factor ISGF3γ in virus-induced expression of the IFN-β gene, FEBS Lett. 358 (1995) 225-229.
76. [76] Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Kimura T., Kitagawa M., Yokochi T., Sok-Pin Tan R., Takasugi T., Kadokawa Y., Schindler C., Schreiber R.D., Noguchi S., Taniguchi T., Regulation of IFN α/β genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN α/β, Gene Cells 1 (1996) 995-1005.
77. [77] Yoneyama M., Suhara W., Fukuhara Y., Sato M., Ozato K., Fujita T., Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3), J. Biochem. 120 (1996) 160-169.
78. [78] Daly C., Reich N.C., Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon α/β-stimulated genes, J. Biol, Chem. 270 (1995) 23739-23746.
79. [79] Darnell J.E. Jr., Kerr I.M., Stark G.R., Jak-STAT pathways and trans-criptional activation in response to IFNs and other extracellular signaling proteins, Science 264 (1994) 1415-1421.
80. [80] Au W.C., Moore P.A., Lowther W., Juang Y.T., Pitha P.M., Identification of a member of interferon regulatory factor family that binds to the interferon stimulated response element and activates expression of interferon-induced-genes, Proc. Natl. Acad. Sci. USA 92 (1995) 11657-11661.
81. [81] Schafer S., Lin R., Moore P., Hiscott J., Pitha P.M., Regulation of type I interferon gene expression by interferon regulatory factor 3, J. Biol. Chem. 273 (1998) 2714-2720.
82. [82] Lin R., Heylbroeck C., Pitha P., Hiscott J., Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential and proteasome-mediated degradation, Mol. Cell. Biol. 18 (1998) 2986-2996.
83. [83] Weaver B.K., Kumar K.P., Reich N.C., Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1, Mol. Cell. Biol. 18 (1998) 1359-1368.
84. [84] Yoneyama M., Suhara W., Fujuhara Y., Fujita T., Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing of IRF-3 and CBP/P300, EMBO J. 17 (1998) 1087-1095.
85. [85] Keller A., Maniatis T., Identification of an inducible factor that binds to a positive regulatory element of the human β-interferon gene, Proc. Natl. Aad. Sci. USA 85 (1988) 3309-3313.
86. [86] Levy E., Kessler D.S., Pine R., Reich N., Darnell J.E., Interferon-β induced factors that bind a shared promoter element correlate with positive and negative transcription control, Gene Dev. 2 (1988) 383-393.
87. [87] Palombella V.J., Maniatis T., Inducible processing of interferon regulatory factor-2, Mol. Cell. Biol. 12 (1992) 325-3336.
88. [88] Cohen L., Hiscott J., Characterization of TH3, an induction-specific protein interacting with the interferon β promoter, Virology 191 (1992) 589-599.
89. [89] Whiteside S.T., Visvanathan K.V., Goodbourn S., Identification of novel factors that bind the PRD1 region of the human β-interferon promoter, Nucleic Acids Res. 20 (1992) 1531-1538.
90. [90] Lin R., Mustafa A., Nguyen H., Hiscott J., Mutational analysis of interferon (IFN) regulatory factors 1 and 2: effects on the induction of IFN-β gene expression, J. Biol. Chem. 269 (1994) 17542-17549.
91. [91] Whiteside S.T., King P., Goodbourn S., A truncated form of the IRF-2 transcription factor has the properties of a postinduction represser of interferon-β gene expression, J. Biol. Chem. 269 (1994) 27059-27065.
92. [92] Yamamoto H., Lamphier M.S., Fujita T., Taniguchi T., Harada H., The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain, Oncogene 9 (1994) 1423-1428.
93. [93] Nguyen H., Mustafa A., Hiscott J., Lin R., Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain, Oncogene 11 (1995) 537-544.
94. [94] Vaughan P.S., Aziz F., VanVijnen A.J., Wu S., Harada H., Taniguchi T., Soprano K.J., Stein J.L., Stein G.S., Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2, Nature 377 (1995) 362-365.
95. [95] Luo W., Skalnik D.G., Interferon regulatory factor-2 directs transcription from the gp91 phox promoter, J. Biol. Chem. 271 (1996) 23445-23451.
96. [96] Schaefer B.C., Paulson E., Strominger J.L., Speck S.H., Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency, Mol. Cell. Biol. 17 (1997) 873-886.
97. [97] Bolaventa C., Driggers P.H., Marks M.S., Medin J.A., Politis A.D., Vogel S.N., Levy D.E., Sakaguchi K., Appella E., Coligan J.E., Ozato K., Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family, Proc. Natl. Acad. Sci. USA 91 (1994) 5046-5050.
98. [98] Sharf R., Azriel A., Lejbkowicz F., Winograd S.S., Ehrlich R., Levi B.Z., Functional domain analysis of interferon consensus binding protein (ICSBP) and its association with interferon regulatory factors, J. Biol. Chem. 270 (1995) 13063-13069.
99. [99] Wang I.M., Blanco J.C.G., Tsai S.Y., Tsai M.J., Ozato K., Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro, Mol. Cell. Biol. 16 (1996) 6313-6324.
100. [100] Sharf R., Meraro D., Azriel A., Thornton A.M., Ozato K., Petricoin E.F., Larner A.C., Schaper F., Hauser H., Levi B.Z., Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA, J. Biol. Chem. 272 (1997) 9785-9792.
101. [101] Driggers P.H., Ennist D.L., Gleason S.L., Mak W.H., Marks M.S., Levi B.Z., Flanagan J.R., Appella E., Ozato K., An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes, Proc. Natl. Acad. Sci. USA 87 (1990) 3743-3747.
102. [102] Weisz A., Marx P., Sharf R., Appella E., Driggers P.H., Ozato K., Levi B.Z., Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes, J. Biol. Chem. 267 (1992) 25589-25596.
103. [103] Nelson N., Marks M.S., Driggers P.H., Ozato K., Interferon consensus sequence binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription, Mol. Cell. Biol. 13 (1993) 588-599.
104. [104] Holtschke T., Löhler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gavriele L., Waring J.F., Bachmann M.F., Zingernagel R.M., Morse III H.C., Ozato K., Horak I., Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene, Cell 87 (1996) 307-317.
105. [105] Eisenbeis C.F., Singh H., Storb U., Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator, Genes Dev. 9 (1995) 1377-1387.
106. [106] Matsuyama T., Grossman A., Mittrücker H.W., Siderovski O.P., Kiefer F., Kawakami T., Richardson C.D., Taniguchi T., Yoshinaga S.K., Mak T.W., Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE), Nucleic Acids Res. 23 (1995) 2127-2136.
107. [107] Yamagata T., Nishida J., Tanaka T., Sakai R., Mitani K., Yoshida M., Taniguchi T., Yazaki Y., Hirai H., A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes, Mol. Cell. Biol. 16 (1996) 1283-1294.
108. [108] Mittrücker H.W., Matsuyama T., Grossman A., Künding T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S., Mak T.W., Requirement for the transcription factor LSIRF/IRF4 for mature B ant T lymphocyte function, Science 275 (1997) 540-543.
109. [109] Zhang L., Pagano J.S., IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency, Mol. Cell. Biol. 17 (1997) 5748-5757.
110. [110] Keller A.D., Maniatis T., Identification and characterization of a novel represser of β-interferon gene expression, Genes Dev. 5 (1991) 868-879.
111. [111] Hiscott J., Alper D., Cohen L., Leblanc J.F., Sportza L., Wong A., Xanthoudakis S., Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-κB site of the human immunodeficiency virus enhancer, J. Virol. 63 (1989) 2557-2566.
112. [112] Lenardo M.J., Fan C.M., Maniatis T., Baltimore D., The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction, Cell 57 (1989) 287-294.
113. [113] Visvanathan K., Goodbourn S., Double-stranded RNA activates binding of NF-κB to an inducible element in the human β-interferon promoter, EMBO J. 8 (1989) 1129-1138.
114. [114] Beg A., Baldwin A.S., The IκB proteins: regulators of Re1/NF-κB transcription factors, Genes Dev. 7 (1993) 2064-2070.
115. [115] Haskill S., Beg A.A., Tompkins S.M., Morris J.S., Yurochko A.D., Sampson-Johannes K., Mondal A., Ralph P., Baldwin Jr. A.S., Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity, Cell 65 (1991) 1281-1289.
116. [116] Beg A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin Jr. A.S., IκB interacts with the nuclear localization sequences of the subunits of NF-κB a mechanism for cytoplasmic retention, Genes Dev. 6 (1992) 1899-1913.
117. [117] Scott M.L., Fujita T., Liou H.C., Nolan G.P., Baltimore D., The p65 subunit of NF-κB regulates IκB by two distinct mechanisms, Genes Dev. 7 (1993) 1266-1276.
118. [118] Beg A.A., Finco T.S., Nantermet P.V., Baldwin Jr. A.S., Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBa: a mechanism for NF-κB activation, Mol. Cell. Biol. 13 (1993) 3301-3310.
119. [119] Brown K., Park S., Kanno T., Tranzoso G., Siebenlist U., Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α, Proc. Natl. Acad. Sci. USA 90 (1993) 2532-2536.
120. [120] Le Bail O., Schmidt-Ullrich R., Israel A., Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family, EMBO J. 12 (1993) 5042-5049.
121. [121] Sun S.C., Ganchi P.A., Ballard D.W., Greene W.C., NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway, Science 259 (1993) 1912-1915.
122. [122] Garoufalis E., Ewan I., Lin R., Mustafa A., Pepin N., Roulston A., Lacoste J., Hiscott J., Viral induction of the human Interferon β promoter: modulation of transcription by NF-κB/rel proteins and Interferon regulatory factors, J. Virol. 68 (1994) 4707-4715.
123. [123] Roulston A., Beauparlant P., Rice N., Hiscott J., Chronic HIV-1 infection induces distinct NF-κB/rel DNA binding activities in myeloblastic cells, J. Virol. 67 (1993) 5235-5246.
124. [124] Miyamoto S., Chiao P.J., Verma I.M., Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines, Mol. Cell. Biol. 14 (1994) 3276-3282.
125. [125] Kumar A., Haque J., Lacoste J., Hiscott J., Williams B.R.G., The dsRNA dependent protein kinase PKR activates transcription factor NF-κB by phosphorylating IκB, Proc. Natl. Acad. Sci. USA 91 (1994) 6288-6292.
126. [126] Fan C.M., Maniatis T., A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence, Genes Dev. 4 (1990) 29-42.
127. [127] Lehming N., Thanos D., Brickman J.M., Ma J., Maniatis T., Ptashne M., An HMG-like protein that can switch a transcriptional activator to a repressor, Nature 371 (1994) 175-179.
128. [128] Kirov N.C., Lieberman P.M., Rushlow C., The transcriptional corepressor DSP1 inhibits activated transcription by disrupting TFIIA-TBP complex formation, EMBO J. 15 (1996) 7079-7087.
129. [129] Nourbakhsh M., Hauser H., The transcriptional silencer protein NRF: a repressor of NF-κB enhancers, Immunobiology 198 (1997) 65-72.
130. [130] Thanos D., Maniatis T., The high mobility group protein HMG I (Y) is required for NFκB-dependent virus induction of the human IFN-β gene, Cell 71 (1992) 777-789.
131. [131] Lewis H., Kaszubska W., Delamarter J.F., Whelan J., Cooperativity between NF-κB complexes, mediated by high-mobility-group protein I (Y), is essential for cytokine-induced expression expression of the E-selectin promoter, Mol. Cell. Biol. 14 (1994) 5701-5709.
132. [132] Whitley M.Z., Thanos D., Read M.A., Maniatis T., Collins T., A striking similariry in the organization of the E-selectin and the β interferon gene promoters, Mol. Cell. Biol. 14 (1994) 6464-6475.
133. [133] Chuvpilo S., Schomberg C., Gerwig R., Heinflin A., Reeves R., Grummt F., Serfling E., Multiple closely-linked NFAT/octamer and HMG I (Y) binding sites are part of the interleukin-4 promoter, Nucleic Acids Res. 21 (1993) 5694-5704.
134. [134] John S., Reeves R.B., Lin J.X., Child R., Leiden J.M., Thompson C.B., Leonard W.J., Regulation of cell-type-specih'c interleukine-2 receptor α-chain gene expression: potential role of physical interaction of Elf-1, HMG-I (Y), and NF-κB family protein, Mol. Cell. Biol, 15 (1995) 1786-1796.
135. [135] Fashena S.J., Reeves R., Ruddle N.H., A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor β) gene regulation, Mol. Cell. Biol. 12 (1992) 894-903.
136. [136] French S.W., Schmidt M.C., Glorioso J.C., Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2, Mol. Cell. Biol. 16 (1996) 5393-5399.
137. [137] Leger H., Sock E., Renner K., Grummt F., Wegner M., Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I (Y), Mol. Cell. Biol. 15 (1995) 3738-3747.
138. [138] Thanos D., Maniatis T., Virus induction of IFN β gene expression requiRes. of the assembly of an enhanceosome, Cell 83 (1995) 1091-1100.
139. [139] Falvo J.V., Thanos D., Maniatis T., Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I (Y), Cell 83 (1995) 1101-1111.